CORE--Pharmaokinetics

$27,295P30FY2005CANIH

Oregon Health And Science University, Portland OR

Investigators

Linked publications & trials

Paper 39764100 Paper 39763867 Paper 39605535 Paper 39435649 Paper 39386578 Paper 39375962 Paper 39337350 Paper 39273147 Paper 39211582 Paper 39131374 Paper 39108237 Paper 39079535 Paper 39030653 Paper 39028280 Paper 39023197 Paper 38905574 Paper 38902487 Paper 38895265 Paper 38885176 Paper 38862858 Paper 38854129 Paper 38849085 Paper 38639936 Paper 38632714 Paper 38578949 Paper 38384895 Paper 38361951 Paper 38354260 Paper 38300710 Paper 38195933 Paper 38162122 Paper 38106024 Paper 38092437 Paper 38039316 Paper 37961180 Paper 37960281 Paper 37814009 Paper 37713024 Paper 37683260 Paper 37679472 Paper 37670377 Paper 37669266 Paper 37645790 Paper 37644723 Paper 37569869 Paper 37538330 Paper 37506755 Paper 37488533 Paper 37453163 Paper 37451763 Paper 37380935 Paper 37380658 Paper 37365517 Paper 37301933 Paper 37191732 Paper 37096733 Paper 37083005 Paper 37001528 Paper 36993571 Paper 36945588 Paper 36840904 Paper 36824803 Paper 36480243 Paper 36230539 Paper 36224384 Paper 36219587 Paper 36173894 Paper 36041632 Paper 36010865 Paper 35894778 Paper 35885487 Paper 35868306 Paper 35804998 Paper 35646545 Paper 35614104 Paper 35560013 Paper 35545666 Paper 35500223 Paper 35439295 Paper 35389288 Paper 35385329 Paper 35380701 Paper 35343367 Paper 35253976 Paper 35243422 Paper 35241737 Paper 35195258 Paper 35177378 Paper 35175278 Paper 35132620 Paper 35091459 Paper 35078224 Paper 34993663 Paper 34990293 Paper 34964803 Paper 34911933 Paper 34839002 Paper 34741653 Paper 34732713 Paper 34689087

Abstract

The Pharmacokinetics (PK) Shared Resource is a shared resource that functions as a specialized service laboratory providing technical support to investigators who wish to quantify small molecule concentrations in clinical or preclinical material. The PSR provides consultation on design of pharmacokinetic studies and assistance with the analysis of PK data. The Specific Aims of the facility are: 1) to provide Cancer Institute members access to state of the art LC and GC mass spectrometry and HPLC equipment; 2) to provide Institute members with a full service laboratory that can develop analytical methods, prepare samples and provide data analysis for both clinical and basic science investigations, and 3) to provide Institute members with assistance in the design and interpretation of pharmacokinetic and pharmacodynamic studies for both animal models and Phase I investigations.

View original record on NIH RePORTER →